Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Development and in vitro characterization of mebendazole delayed release tablet for colonic drug delivery.

Baviskar D, Rajput A, Bare K, Biranwar Y, Chaudhari H, Narkhede D, Jain D.

Pak J Pharm Sci. 2014 Mar;27(2):249-53.

PMID:
24577910
2.

Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of mebendazole in healthy volunteers.

Krishnaiah YS, Veer Raju P, Dinesh Kumar B, Satyanarayana V, Karthikeyan RS, Bhaskar P.

J Control Release. 2003 Feb 14;88(1):95-103.

PMID:
12586507
3.

Development of colon targeted drug delivery systems for mebendazole.

Krishnaiah YS, Veer Raju P, Dinesh Kumar B, Bhaskar P, Satyanarayana V.

J Control Release. 2001 Nov 9;77(1-2):87-95.

PMID:
11689262
4.

Excipient-excipient interaction in the design of sustained-release theophylline tablets: in vitro and in vivo evaluation.

Bayomi MA, Al-Suwayeh SA, El-Helw AR.

Drug Dev Ind Pharm. 2001 Jul;27(6):499-506.

PMID:
11548856
5.

Studies on stercuia gum formulations in the form of osmotic core tablet for colon-specific drug delivery of azathioprine.

Nath B, Nath LK.

PDA J Pharm Sci Technol. 2013 Mar-Apr;67(2):172-84. doi: 10.5731/pdajpst.2013.00913.

PMID:
23569078
6.

Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.

Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S.

Arch Pharm Res. 2007 Feb;30(2):222-34.

PMID:
17366745
7.

Effect of two hydrophobic polymers on the release of gliclazide from their matrix tablets.

Hussain T, Saeed T, Mumtaz AM, Javaid Z, Abbas K, Awais A, Idrees HA.

Acta Pol Pharm. 2013 Jul-Aug;70(4):749-57.

8.

A study on maize proteins as a potential new tablet excipient.

Georget DM, Barker SA, Belton PS.

Eur J Pharm Biopharm. 2008 Jun;69(2):718-26. doi: 10.1016/j.ejpb.2008.01.006. Epub 2008 Jan 18.

PMID:
18294824
9.

Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.

Ali KA, Mukherjee B, Bandyopadhyay AK.

Drug Dev Ind Pharm. 2013 Nov;39(11):1742-9. doi: 10.3109/03639045.2012.733011. Epub 2012 Dec 6.

PMID:
23216220
10.

Sugar end-capped poly-D,L-lactides as excipients in oral sustained release tablets.

Vuorinen S, Heinämäki J, Antikainen O, Lahcini M, Repo T, Yliruusi J.

AAPS PharmSciTech. 2009;10(2):566-73. doi: 10.1208/s12249-009-9247-9. Epub 2009 May 9.

11.

Chitosan-chondroitin sulfate based matrix tablets for colon specific delivery of indomethacin.

Amrutkar JR, Gattani SG.

AAPS PharmSciTech. 2009;10(2):670-7. doi: 10.1208/s12249-009-9253-y. Epub 2009 May 21.

12.

Formulation and evaluation of floating tablet of H2-receptor antagonist.

Kesarla RS, Vora PA, Sridhar BK, Patel G, Omri A.

Drug Dev Ind Pharm. 2015;41(9):1499-511. doi: 10.3109/03639045.2014.959969. Epub 2015 Jul 21.

PMID:
25243639
13.

Evaluation of the gum from Hakea gibbosa as a sustained-release and mucoadhesive component in buccal tablets.

Alur HH, Pather SI, Mitra AK, Johnston TP.

Pharm Dev Technol. 1999 Aug;4(3):347-58.

PMID:
10434280
14.

Characterization of chitosan acetate as a binder for sustained release tablets.

Nunthanid J, Laungtana-Anan M, Sriamornsak P, Limmatvapirat S, Puttipipatkhachorn S, Lim LY, Khor E.

J Control Release. 2004 Sep 14;99(1):15-26.

PMID:
15342177
15.

A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.

Krishnaiah YS, Karthikeyan RS, Satyanarayana V.

Int J Pharm. 2002 Jul 25;241(2):353-66.

PMID:
12100863
16.
17.

Formulation of sustained-release dosage form of verapamil hydrochloride by solid dispersion technique using Eudragit RLPO or Kollidon SR.

Sahoo J, Murthy PN, Biswal S, Manik.

AAPS PharmSciTech. 2009;10(1):27-33. doi: 10.1208/s12249-008-9175-0. Epub 2009 Jan 15.

18.

In vivo pharmacokinetics in human volunteers: oral administered guar gum-based colon-targeted 5-fluorouracil tablets.

Krishnaiah YS, Satyanarayana V, Dinesh Kumar B, Karthikeyan RS, Bhaskar P.

Eur J Pharm Sci. 2003 Aug;19(5):355-62.

PMID:
12907286
19.

Formulation and evaluation of Ficus glomerata mucilage sustained release matrix tablets of gliclazide.

Kumar CS, Reddy-Budideti KK, Battula SP, Ayyavala CS.

Pak J Pharm Sci. 2011 Jul;24(3):399.

PMID:
21715275
20.

Citric acid as excipient in multiple-unit enteric-coated tablets for targeting drugs on the colon.

Nykänen P, Lempää S, Aaltonen ML, Jürjenson H, Veski P, Marvola M.

Int J Pharm. 2001 Oct 23;229(1-2):155-62.

PMID:
11604268
Items per page

Supplemental Content

Write to the Help Desk